Skip to main content
. 2021 Jul 14;12:633214. doi: 10.3389/fimmu.2021.633214

Figure 2.

Figure 2

Significant differences in glycan measurements in patients with no skin cGvHD and among various degrees of skin NIH cGvHD severity.